Eprocliv (Metformin Hydrochloride, Sitagliptin)

Eprocliv combines Metformin Hydrochloride and Sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Eprocliv is primarily used to manage type 2 diabetes in adults. It works by improving insulin sensitivity and increasing insulin production, helping to regulate blood sugar levels. This medication is often prescribed alongside diet and exercise for better glycemic control.

Common effects of Eprocliv may include gastrointestinal discomfort, such as nausea or diarrhea, especially when starting treatment. Some users may also experience headaches or dizziness. These effects typically subside as the body adjusts to the medication.

Eprocliv should be used with caution in individuals with kidney or liver issues. It is important to monitor blood sugar levels regularly and consult a healthcare provider before starting or adjusting the dosage. Avoid alcohol consumption while using this medication.

Eprocliv may interact with certain medications, including diuretics, corticosteroids, and some antibiotics. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the prescribed dosage and usage instructions.